Finance Lease ROU Assets (Details) |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Mar. 31, 2025
USD ($)
|
Mar. 31, 2024
USD ($)
|
Mar. 31, 2025
USD ($)
|
Mar. 31, 2024
USD ($)
|
Jun. 30, 2024
USD ($)
|
Sep. 16, 2022 |
Sep. 16, 2022
lease
|
|
Lessee, Lease, Description [Line Items] | |||||||
Net finance lease ROU assets | $ 136,000 | $ 136,000 | $ 339,000 | ||||
Amortization expense - ROU assets | 203,000 | $ 203,000 | |||||
Continuing Operations | |||||||
Lessee, Lease, Description [Line Items] | |||||||
Amortization expense - ROU assets | 68,000 | $ 67,000 | |||||
RubrYc Therapeutics | Asset Purchase Agreement | |||||||
Lessee, Lease, Description [Line Items] | |||||||
Number of equipment leases assumed in asset acquisition | 3 | 3 | |||||
Equipment | |||||||
Lessee, Lease, Description [Line Items] | |||||||
ROU - Equipment | 814,000 | 814,000 | 814,000 | ||||
Accumulated amortization | (678,000) | (678,000) | (475,000) | ||||
Net finance lease ROU assets | 136,000 | 136,000 | $ 339,000 | ||||
Equipment | Continuing Operations | |||||||
Lessee, Lease, Description [Line Items] | |||||||
Amortization expense - ROU assets | $ 68,000 | $ 67,000 | $ 203,000 | $ 203,000 |